marketcap
Facebook
Twitter
Telegram
Report an ErrorAcceleron Pharma Inc. Financial Statements 2011-2024 | XLRN
Annual Financial Statements Acceleron Pharma Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
6.89 B | 4.53 B | 1.91 B | 1.75 B | 877 M | 1.02 B | 1.24 B | 467 M | - | - |
Shares |
56.8 M | 52.5 M | 45.9 M | 40.4 M | 37.4 M | 33.3 M | 31.5 M | 9.41 M | - | - |
Net Income |
-125 M | -125 M | -119 M | -108 M | -57 M | -63.9 M | -51.3 M | -21.9 M | -32.6 M | 36.3 M |
Revenue |
74 M | 74 M | 14 M | 13.5 M | 27.8 M | 18.1 M | 14.6 M | 57.2 M | 15.3 M | 80.9 M |
EBITDA |
-133 M | -133 M | -121 M | -107 M | -64.4 M | -59.7 M | -49.3 M | 7.87 M | -27.6 M | 41.7 M |
Operating Expenses |
210 M | 210 M | 138 M | 123 M | 93.9 M | 79 M | 65.1 M | 50.3 M | 44.1 M | 40.9 M |
General and Administrative Expenses |
56.5 M | - | 34.5 M | 33.7 M | 25.3 M | 20.6 M | 14.2 M | 14.2 M | 8.82 M | 8.14 M |
All numbers in USD currency